Vimarsana
Biggest News Aggregation in the World

Page 16 - Material Command News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Material Command. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Material Command Today - Breaking & Trending Today

CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled - Vimarsana News

CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled

Published: November 14, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Source: prnewswire.com
Related Topics:
United StatesEfthymiosn DeliargyrisJosephine KrausEric KimMarcus SchultMichaelj MackKathleen BlochMaterial CommandEuropean Company ContactCardiovascular ServiceEuropean UnionBaylor Plano Research CenterUs ArmyBlood InstituteNational HeartCytosorbents CorporationNational Institutes Of HealthHuman ServicesUs Department Of HealthUs AirBaylor Scott White Health SystemHealth CanadaSorbents CorporationTimely Antithrombotic RemovalSafety Monitoring Board
CytoSorbents Reports Third Quarter 2022 Financial and Operational Results - Vimarsana News

CytoSorbents Reports Third Quarter 2022 Financial and Operational Results

Published: November 3, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Source: prnewswire.com
Related Topics:
New JerseyUnited StatesState Of New JerseyJosephine KrausAstra ZenecaPhillip ChanMarcus SchultKathleen BlochJanssen BayerUs Centers Of DiseaseDepartment Of DefenseEuropean Company ContactMaterial CommandUs National Institutes Of HealthTurkish Ministry Of HealthEuropean Association For CardioEuropean UnionUs ArmyBlood InstituteNational HeartCytosorbents CorporationNational InstituteEuropean Society Of Intensive Care MedicineBus Company ContactUs Department Of Health
CytoSorbents Reports Third Quarter 2022 Financial and Operational Results - Vimarsana News

CytoSorbents Reports Third Quarter 2022 Financial and Operational Results

Published: November 3, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Source: prnewswire.com
Related Topics:
New JerseyUnited StatesState Of New JerseyJosephine KrausAstra ZenecaPhillip ChanMarcus SchultKathleen BlochJanssen BayerUs Centers Of DiseaseDepartment Of DefenseEuropean Company ContactMaterial CommandUs National Institutes Of HealthTurkish Ministry Of HealthEuropean Association For CardioEuropean UnionUs ArmyBlood InstituteNational HeartCytosorbents CorporationNational InstituteEuropean Society Of Intensive Care MedicineBus Company ContactUs Department Of Health
CytoSorbents Reports Third Quarter 2022 Financial and Operational Results - Vimarsana News

CytoSorbents Reports Third Quarter 2022 Financial and Operational Results

Published: November 3, 2022

CytoSorbents expects to achieve first milestone of the U.S. pivotal STAR-T Trial this monthPRINCETON, N.J., Nov. 3, 2022 /PRNewswire/ -- CytoSorbe...

Source: businessinsider.com
Related Topics:
New JerseyUnited StatesState Of New JerseyAstra ZenecaPhillip ChanJanssen BayerUs Centers Of DiseaseDepartment Of DefenseMaterial CommandUs National Institutes Of HealthTurkish Ministry Of HealthEuropean Association For CardioEuropean UnionUs ArmyBlood InstituteCytosorbents CorporationNational HeartNational InstituteEuropean Society Of Intensive Care MedicineUs Department Of HealthHuman ServicesNational Institutes Of HealthUs AirCompany FormIsraeli Ministry Of Health
'Enhanced Lung Rest' with CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients with Refractory Lung Failure from Five Major U.S. Hospitals - Vimarsana News

'Enhanced Lung Rest' with CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients with Refractory Lung Failure from Five Major U.S. Hospitals

Published: November 2, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Source: prnewswire.com
Related Topics:
France GeneralUnited StatesJw Awori HayangaJosephine KrausJoerg ScheierMarcus SchultKathleen BlochCytosorbents Europe GmbEric KimRobert BartlettPhillip ChanMaterial CommandVirginia University School Of MedicineEuropean UnionUs ArmyBlood InstituteCytosorbents CorporationNational HeartEuropean Society Of Intensive Care MedicineInternational Extracorporeal Life Support OrganizationNational Institutes Of HealthHuman ServicesUs Department Of HealthDrug AdministrationUs Air